These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 22082482)

  • 1. The emerging role of endocrine disruptors in pathogenesis of insulin resistance: a concept implicating nonalcoholic fatty liver disease.
    Polyzos SA; Kountouras J; Deretzi G; Zavos C; Mantzoros CS
    Curr Mol Med; 2012 Jan; 12(1):68-82. PubMed ID: 22082482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Endocrine-Disrupting Chemicals in the Pathogenesis of Non-Alcoholic Fatty Liver Disease: A Comprehensive Review.
    Cano R; Pérez JL; Dávila LA; Ortega Á; Gómez Y; Valero-Cedeño NJ; Parra H; Manzano A; Véliz Castro TI; Albornoz MPD; Cano G; Rojas-Quintero J; Chacín M; Bermúdez V
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34062716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between endocrine disrupting chemicals and nonalcoholic fatty liver disease: A systematic review and meta-analysis.
    Pan K; Xu J; Xu Y; Wang C; Yu J
    Pharmacol Res; 2024 Jul; 205():107251. PubMed ID: 38862070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical Effect of Bisphenol A on Non-Alcoholic Fatty Liver Disease.
    Dallio M; Diano N; Masarone M; Gravina AG; Patanè V; Romeo M; Di Sarno R; Errico S; Nicolucci C; Abenavoli L; Scarpellini E; Boccuto L; Persico M; Loguercio C; Federico A
    Int J Environ Res Public Health; 2019 Aug; 16(17):. PubMed ID: 31466361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Environmental endocrine disruptors: New diabetogens?
    Fénichel P; Chevalier N
    C R Biol; 2017; 340(9-10):446-452. PubMed ID: 28826789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Endocrine-Disrupting Chemicals on the Ovary.
    Patel S; Zhou C; Rattan S; Flaws JA
    Biol Reprod; 2015 Jul; 93(1):20. PubMed ID: 26063868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Endocrine disruptors are a novel direction of endocrinologic scientific investigation].
    Iaglova NV; Iaglov VV
    Vestn Ross Akad Med Nauk; 2012; (3):56-61. PubMed ID: 22712276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocrine-Disrupting Chemicals and the Development of Diabetes Mellitus Type 1: A 5-Year Systematic Review.
    Keskesiadou GN; Tsokkou S; Konstantinidis I; Georgaki MN; Sioga A; Papamitsou T; Karachrysafi S
    Int J Mol Sci; 2024 Sep; 25(18):. PubMed ID: 39337594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Environmental neglect: endocrine disruptors as underappreciated but potentially modifiable diabetes risk factors.
    Sargis RM; Simmons RA
    Diabetologia; 2019 Oct; 62(10):1811-1822. PubMed ID: 31451869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocrine Disruptors and Developmental Origins of Nonalcoholic Fatty Liver Disease.
    Treviño LS; Katz TA
    Endocrinology; 2018 Jan; 159(1):20-31. PubMed ID: 29126168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transgenerational epigenetic effects from male exposure to endocrine-disrupting compounds: a systematic review on research in mammals.
    Van Cauwenbergh O; Di Serafino A; Tytgat J; Soubry A
    Clin Epigenetics; 2020 May; 12(1):65. PubMed ID: 32398147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential mechanisms regarding triclosan vs. bisphenol A and fluorene-9-bisphenol induced zebrafish lipid-metabolism disorders by RNA-Seq.
    Sun L; Ling Y; Jiang J; Wang D; Wang J; Li J; Wang X; Wang H
    Chemosphere; 2020 Jul; 251():126318. PubMed ID: 32143076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exposure to environmental endocrine disruptors and child development.
    Meeker JD
    Arch Pediatr Adolesc Med; 2012 Oct; 166(10):952-8. PubMed ID: 23367522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocrine disrupting chemicals: A promoter of non-alcoholic fatty liver disease.
    Chen Y; Wang Y; Cui Z; Liu W; Liu B; Zeng Q; Zhao X; Dou J; Cao J
    Front Public Health; 2023; 11():1154837. PubMed ID: 37033031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Endocrine-Disrupting Chemicals on Bone Health.
    Park SY; Kong SH; Kim KJ; Ahn SH; Hong N; Ha J; Lee S; Choi HS; Baek KH; Kim JE; Kim SW
    Endocrinol Metab (Seoul); 2024 Aug; 39(4):539-551. PubMed ID: 39015028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disparities in Environmental Exposures to Endocrine-Disrupting Chemicals and Diabetes Risk in Vulnerable Populations.
    Ruiz D; Becerra M; Jagai JS; Ard K; Sargis RM
    Diabetes Care; 2018 Jan; 41(1):193-205. PubMed ID: 29142003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between endocrine-disrupting chemical mixtures and non-alcoholic fatty liver disease with metabolic syndrome as a mediator among adults: A population-based study in Korea.
    Park B; Kim B; Kim CH; Oh HJ; Park B
    Ecotoxicol Environ Saf; 2024 May; 276():116310. PubMed ID: 38614002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transgenerational Effects of Endocrine-Disrupting Chemicals on Male and Female Reproduction.
    Brehm E; Flaws JA
    Endocrinology; 2019 Jun; 160(6):1421-1435. PubMed ID: 30998239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Endocrine Disruptors Bisphenols and Phthalates in Obesity: Current Evidence, Perspectives and Controversies.
    Dalamaga M; Kounatidis D; Tsilingiris D; Vallianou NG; Karampela I; Psallida S; Papavassiliou AG
    Int J Mol Sci; 2024 Jan; 25(1):. PubMed ID: 38203845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bisphenol A: Targeting metabolic tissues.
    Chevalier N; Fénichel P
    Rev Endocr Metab Disord; 2015 Dec; 16(4):299-309. PubMed ID: 26820262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.